Age, Biography and Wiki
Lorenzo Galluzzi was born on 26 September, 1980. Discover Lorenzo Galluzzi's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 40 years old?
|Age||40 years old|
|Born||26 September 1980|
We recommend you to check the complete list of Famous People born on 26 September. He is a member of famous with the age 40 years old group.
Lorenzo Galluzzi Height, Weight & Measurements
At 40 years old, Lorenzo Galluzzi height not available right now. We will update Lorenzo Galluzzi's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
|Body Measurements||Not Available|
|Eye Color||Not Available|
|Hair Color||Not Available|
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
Lorenzo Galluzzi Net Worth
His net worth has been growing significantly in 2019-2020. So, how much is Lorenzo Galluzzi worth at the age of 40 years old? Lorenzo Galluzzi’s income source is mostly from being a successful . He is from . We have estimated Lorenzo Galluzzi's net worth, money, salary, income, and assets.
|Net Worth in 2020||$1 Million - $5 Million|
|Salary in 2019||Under Review|
|Net Worth in 2019||Pending|
|Salary in 2019||Under Review|
|Source of Income|
Lorenzo Galluzzi Social Network
|Wikipedia||Lorenzo Galluzzi Wikipedia|
In addition to his research and dissemination activity, Galluzzi currently operates as Editor-in-Chief of three journals: OncoImmunology (which he co-founded with Dr. Guido Kroemer and Dr. Laurence Zitvogel in 2011), International Review of Cell and Molecular Biology, and Molecular and Cellular Oncology (which he co-founded with Dr. Guido Kroemer in 2013). Galluzzi also serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease and Aging.
Galluzzi is best known for his experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. In particular, he provided profound insights into the links between adaptive stress responses in cancer cells and the activation of a clinically relevant tumor-targeting immune response in the context of chemotherapy and radiation therapy. As of today, Galluzzi has published more than 400 scientific articles in more than 100 different international peer-reviewed journals, collaborating with more than 3,000 co-authors. According to Google Scholar, Galluzzi has a h-index of 109, placing him amongst the top-50 Italian scientists working in biomedical sciences. According to a survey published by Lab Times, he is currently the 6th and the youngest of the 30 most-cited European cell biologists (relative to the period 2007–2013).
Lorenzo Galluzzi (born 1980) is an Italian and French cell biologist best known for his experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology.
Galluzzi (born September 26, 1980) is currently Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College (New York, USA), Assistant Professor Adjunct at the Department of Dermatology of the Yale University School of Medicine (New Haven, USA), and Honorary Associate Professor at the Faculty of Medicine of the Paris Descartes University (Paris, France). Prior to joining Weill Cornell Medical College (2017), Galluzzi was a Junior Scientist of the Research Team "Apoptosis, Cancer and Immunity" at the Cordeliers Research Center (Paris, France; 2012-2016) under the direction of Dr. Guido Kroemer. Galluzzi did his post-doctoral training at the Gustave Roussy Cancer Center (Villejuif, France; 2009-2011), after receiving his PhD from the Paris Sud University (Le Kremlin-Bicetre, France; 2005-2008). Galluzzi is Associate Director of the European Academy for Tumor Immunology (EATI), and Founding Member of the European Research Institute for Integrated Cellular Pathology (ERI-ICP).